Compounded GLP-1 formulations allow individualized dosing that may enhance tolerability in this sensitive population
However, Banerjee et al
Acknowledgments This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Foundayo will be the second oral GLP-1 drug available to consumers, after competitor Novo Nordisk introduced its Wegovy pill in January
The wild success of GLP-1 drugs, which raised awareness of peptides, has partly fueled the boom, along with growing interest among the wealthy in biohackingusing regimens and supplements to improve the bodys performance and longevity and glowing testimonials from social media influencers and peptide converts
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits